glp-1 black box warning TGA issues over GLP-1-based drugs' potential to cause rare eye disorder FDA Says to Drop Suicide

For semaglutide injections, the FDA determined the shortage was resolved in February 2025 and subsequently laid out time-limited enforcement discretion windows

Consent to Participate Not applicable

However, rapid weight lossespecially when achieved without proper nutrition and exercisecan result in the loss of both fat and muscle

The multidistrict litigation against the pharmaceutical giants that made Trulicity and other GLP-1 drugs has grown to 1,521 pending lawsuits on the federal level, with more cases being filed in state courts across the country

Other options include oral medications, such as Weigh In combining bupropion, naltrexone, and metformin

Brand-name Wegovy and Zepbound list between $900 and over $1,500 per month without insurance